Cargando…

Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient

Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose re...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Jonas, Seith, Ferdinand, Estler, Arne, Nikolaou, Konstantin, Schmidt, Holger, la Fougère, Christian, Küstner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611106/
https://www.ncbi.nlm.nih.gov/pubmed/37888735
http://dx.doi.org/10.3390/tomography9050143
_version_ 1785128413741187072
author Vogel, Jonas
Seith, Ferdinand
Estler, Arne
Nikolaou, Konstantin
Schmidt, Holger
la Fougère, Christian
Küstner, Thomas
author_facet Vogel, Jonas
Seith, Ferdinand
Estler, Arne
Nikolaou, Konstantin
Schmidt, Holger
la Fougère, Christian
Küstner, Thomas
author_sort Vogel, Jonas
collection PubMed
description Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose reduction. We performed a phantom study to compare HIs/TFs of simulated and measured tracer dose reductions and evaluated changes of HIs/TFs in the liver of patients with PETs from simulated reduced tracer doses. Overall, 42 HIs/TFs were evaluated in a NEMA phantom at measured and simulated doses (stepwise reduction of [18 F] from 100% to 25% of the measured dose). [18 F]-FDG-PET datasets of 15 patients were simulated from 3.0 down to 0.5 MBq/kgBW in intervals of 0.25 MBq/kgBW. HIs/TFs were calculated from two VOIs placed in physiological tissue of the right and left liver lobe and linear correlations and coefficients of variation analysis were performed. Results: All 42 TFs did not differ significantly in measured and simulated doses (p > 0.05). Also, 40 TFs showed the same behaviour over dose reduction regarding differences in the same group (measured or simulated), and for 26 TFs a linear behaviour over dose reduction for measured and simulated doses could be validated. Out of these, 13 TFs could be identified, which showed a linear change in TF value in both the NEMA phantom and patient data and therefore should maintain the same informative value when transferred in a dose reduction setting. Out of this Homogeneity 2, Entropy and Zone size non-uniformity are of special interest because they have been described as preferentially considerable for tumour heterogeneity characterization. Conclusions: We could show that there was no significant difference of measured and simulated HIs/TFs in the phantom study and most TFs reveal a linear behaviour over dose reduction, when tested in homogeneous tissue. This indicates that texture analysis in PET might be robust to dose modulations.
format Online
Article
Text
id pubmed-10611106
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106111062023-10-28 Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient Vogel, Jonas Seith, Ferdinand Estler, Arne Nikolaou, Konstantin Schmidt, Holger la Fougère, Christian Küstner, Thomas Tomography Article Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose reduction. We performed a phantom study to compare HIs/TFs of simulated and measured tracer dose reductions and evaluated changes of HIs/TFs in the liver of patients with PETs from simulated reduced tracer doses. Overall, 42 HIs/TFs were evaluated in a NEMA phantom at measured and simulated doses (stepwise reduction of [18 F] from 100% to 25% of the measured dose). [18 F]-FDG-PET datasets of 15 patients were simulated from 3.0 down to 0.5 MBq/kgBW in intervals of 0.25 MBq/kgBW. HIs/TFs were calculated from two VOIs placed in physiological tissue of the right and left liver lobe and linear correlations and coefficients of variation analysis were performed. Results: All 42 TFs did not differ significantly in measured and simulated doses (p > 0.05). Also, 40 TFs showed the same behaviour over dose reduction regarding differences in the same group (measured or simulated), and for 26 TFs a linear behaviour over dose reduction for measured and simulated doses could be validated. Out of these, 13 TFs could be identified, which showed a linear change in TF value in both the NEMA phantom and patient data and therefore should maintain the same informative value when transferred in a dose reduction setting. Out of this Homogeneity 2, Entropy and Zone size non-uniformity are of special interest because they have been described as preferentially considerable for tumour heterogeneity characterization. Conclusions: We could show that there was no significant difference of measured and simulated HIs/TFs in the phantom study and most TFs reveal a linear behaviour over dose reduction, when tested in homogeneous tissue. This indicates that texture analysis in PET might be robust to dose modulations. MDPI 2023-09-27 /pmc/articles/PMC10611106/ /pubmed/37888735 http://dx.doi.org/10.3390/tomography9050143 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vogel, Jonas
Seith, Ferdinand
Estler, Arne
Nikolaou, Konstantin
Schmidt, Holger
la Fougère, Christian
Küstner, Thomas
Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title_full Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title_fullStr Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title_full_unstemmed Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title_short Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
title_sort impact of tracer dose reduction in [18 f]-labelled fluorodeoxyglucose-positron emission tomography ([18 f]-fdg)-pet) on texture features and histogram indices: a study in homogeneous tissues of phantom and patient
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611106/
https://www.ncbi.nlm.nih.gov/pubmed/37888735
http://dx.doi.org/10.3390/tomography9050143
work_keys_str_mv AT vogeljonas impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT seithferdinand impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT estlerarne impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT nikolaoukonstantin impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT schmidtholger impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT lafougerechristian impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient
AT kustnerthomas impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient